Fig. 2From: Verification of B-lymphocyte activating factor’s involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver diseaseDiscrimination of AIH patients in NASH patients and CLD-C patients seropositive for ANA using the revised scoring system. AIH autoimmune hepatitis, NASH nonalcoholic steatohepatitis, CLD-C HCV-related chronic liver diseaseBack to article page